Soleno Therapeutics (SLNO) had the highest return between June 1, 2023 and October 1, 2023 by a mid-cap US stock, returning 458.9%.
| ASSET | DATE | % RETURN |
|---|---|---|
Soleno Therapeutics (SLNO) | 6/1/2023 - 10/1/2023 | 458.9% |
Applied Opt (AAOI) | 6/1/2023 - 10/1/2023 | 400.91% |
Spyre Therapeutics (SYRE) | 6/1/2023 - 10/1/2023 | 276.92% |
United States Cellular (USM) | 6/1/2023 - 10/1/2023 | 198.4% |
Array Digital Infrastructure (AD) | 6/1/2023 - 10/1/2023 | 198.4% |
Telephone and Data Systems (TDS) | 6/1/2023 - 10/1/2023 | 181.01% |
Olema Pharmaceuticals (OLMA) | 6/1/2023 - 10/1/2023 | 138.42% |
Camtek (CAMT) | 6/1/2023 - 10/1/2023 | 115.28% |
Nextnav Acquisition (NN) | 6/1/2023 - 10/1/2023 | 100% |
Praxis Precision Medicines (PRAX) | 6/1/2023 - 10/1/2023 | 98.84% |
Belite Bio Inc ADR (BLTE) | 6/1/2023 - 10/1/2023 | 98.32% |
Centrus Energy (LEU) | 6/1/2023 - 10/1/2023 | 95.86% |
Bitdeer Technologies Group Class A Ordinary Shares (BTDR) | 6/1/2023 - 10/1/2023 | 95.14% |
Alpha Metallurgical Resources (AMR) | 6/1/2023 - 10/1/2023 | 93.46% |
Uranium Energy (UEC) | 6/1/2023 - 10/1/2023 | 88.64% |
Abercrombie & Fitch (ANF) | 6/1/2023 - 10/1/2023 | 83.44% |
Immunovant (IMVT) | 6/1/2023 - 10/1/2023 | 82.81% |
Amneal Pharmaceuticals, Inc Class A Common Stock (AMRX) | 6/1/2023 - 10/1/2023 | 80.34% |
Acm Research (ACMR) | 6/1/2023 - 10/1/2023 | 79.26% |
Paymentus (PAY) | 6/1/2023 - 10/1/2023 | 75.48% |
Miniso Group Holding (MNSO) | 6/1/2023 - 10/1/2023 | 73.08% |
Archer Aviation (ACHR) | 6/1/2023 - 10/1/2023 | 70.37% |
TAL Education (TAL) | 6/1/2023 - 10/1/2023 | 67.77% |
Oceaneering International (OII) | 6/1/2023 - 10/1/2023 | 67.45% |
Modine Manufacturing (MOD) | 6/1/2023 - 10/1/2023 | 67.4% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
